BackShukra Pharmaceuticals Limited Overview

Shukra Pharmaceuticals Limited Long Term Debt

Latest long-term debt for SHUKRAPHAR.BO: $96M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$96.31M
↑ 259.65% YoYΔ $69.53M vs prior year quarter

Peer trimmed avg / median

Loading

Shukra Pharmaceuticals Limited Long Term Debt History

Loading

Shukra Pharmaceuticals Limited vs. peers: Long Term Debt Comparison

Loading

Shukra Pharmaceuticals Limited Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) FAQ

As of the most recent data (September 2026), SHUKRAPHAR.BO shows a long-term debt of $96M. That compares with $27M in the prior-year period — up 259.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SHUKRAPHAR.BO's long-term debt is now $96M (was $27M) — a 259.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Shukra Pharmaceuticals Limited is outperforming or lagging.

Tracking SHUKRAPHAR.BO's long-term debt over time shows whether Shukra Pharmaceuticals Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $96M That compares with $27M in the prior-year period — up 259.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Shukra Pharmaceuticals Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $96M) with ownership activity and broader fundamentals.

Questions & Answers